Venus Remedies Ltd.
VENUSREM Share PricePharmaceuticals & Drugs
₹571.85
8.2 (1.5%)
As on November 14, 2025
Exchange Scrips: BSE526953NSEVENUSREMISININE411B01019
Market Cap ₹ 759 Cr
P/E Ratio 16.87
Dividend Yield N/A
Performance
Market performance
Open563.6
High576
Volumes74,617
Prev571.85
Low557.5
As on2025-11-14
Historical performance
1 Year High581
3 Year High581
5 Year High639
1 Year Low270.25
3 Year Low145.8
5 Year Low116.05
Fundamentals
Company Valuation
Market Cap (₹Cr)
759
Face Value (₹)
10
P/E Ratio
16.87
Dividend Yield
N/A
Investment Returns
1 Year
88.9%
3 Years
183.4%
5 Years
319.7%
10 Years
359.1%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 534.64 | Bullish |
| 10-DMA | 488.27 | Bullish |
| 20-DMA | 467.17 | Bullish |
| 50-DMA | 458.22 | Bullish |
| 100-DMA | 471.77 | Bullish |
| 200-DMA | 403.36 | Bullish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 5 | 5 | 5 | 5 | 5 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 5 | 5 | 5 | 5 | 5 |
| Public Investors | 17720 | 19302 | 19977 | 19766 | 19552 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 16.87.
- 3Y Stock Price CAGR of the stock is 42.3.
- The stock has a beta of 0.9.
- In the last financial year, the company had an EBITDA of ₹845 Million.
- The company generated revenue of ₹6479 Million in the previous financial year.
Venus Remedies Ltd.
571.858.2 (1.5%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1933885.7
No. of Shares: 3382 (Approx)
Performance:93.4%
P/L: ₹933885.7
Top Gainers
Top Losers
| Symbol | Change% |
|---|---|
| TOLINS | 168.46(-10%) |
| FISCHER | 58.75(-10%) |
| WEALTH | 1051.8(-10%) |
| ATL | 31.49(-9%) |
| MASTERTR | 104.98(-8%) |
| THOMASCOTT | 418.7(-8%) |
| MALLCOM | 1270.2(-8%) |
| LAXMIINDIA | 137.12(-7%) |
Peer Comparison
Get Your Portfolio Reviewed
